Prevnar by Pfizer

SCROLL FOR IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

•
Prevnar 20® should not be given to anyone who has had a severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid
•Individuals with weakened immune systems may have a lower immune response. Safety data are not available for these groups
•
In individuals 18 years of age and older, the most common side effects were pain at the injection site, muscle pain, fatigue, headache, and joint pain. Additionally, injection site swelling was also common in individuals 18 through 59 years of age
•
Ask your healthcare provider about the risks and benefits of Prevnar 20. Only a healthcare provider can decide if Prevnar 20 is right for you

INDICATION FOR PREVNAR 20

Prevnar 20 is a vaccine approved for:

•
the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in individuals 6 weeks of age and older
•
the prevention of pneumonia caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in individuals 18 years of age and older
•
The indication for the prevention of pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F in individuals 18 years of age and older is approved based on immune responses. Continued approval may depend on a supportive study

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit https://www.vaers.hhs.gov/reportevent.html or call 1-800-822-7967.

Please see Full Prescribing Information

here

Manufactured by Wyeth Pharmaceuticals LLC.

Marketed by Pfizer Inc.

Please see full Prescribing Information here.